Anthropic has reportedly chosen Morgan Stanley and Goldman Sachs as lead underwriters for its planned Wall Street IPO, with JPMorgan also joining the syndicate. The Claude maker is considering an October 2026 listing after confidentially filing with the SEC on June 1 at a private valuation of about $965 billion.
This article aggregates reporting from 3 news sources. The TL;DR is AI-generated from original reporting. Race to AGI's analysis provides editorial context on implications for AGI development.
Anthropic’s choice of Morgan Stanley and Goldman Sachs as lead underwriters crystallizes that frontier AI is no longer a speculative sideshow but the core of global capital markets. A near‑trillion‑dollar IPO would instantly rank Anthropic among the most valuable public companies, putting hard disclosure, quarterly guidance and investor-return expectations around a firm whose public narrative has leaned heavily on safety and governance. That tension between safety-first branding and shareholder pressure for growth will be one of the defining storylines of the AGI race.
Strategically, an IPO gives Anthropic a deep war chest and liquid stock it can use for acquisitions, talent poaching and long-term compute contracts, narrowing any funding gap with Big Tech incumbents. It also normalizes the idea that AI labs are durable, systemically important infrastructure companies rather than moonshot startups. At the same time, public scrutiny will force more transparency around model performance, safety incidents, and revenue composition, which could sharpen competitive comparisons with OpenAI, Google DeepMind, xAI and others.
For the broader ecosystem, Anthropic’s deal signals that equity markets are prepared to bankroll multi-hundred‑billion‑dollar AI balance sheets. That will embolden late‑stage capital into adjacent players (tools, chips, data infrastructure) and raise the bar for any lab that wants to remain private while still competing at frontier scale.

